| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/05/2006 | CN1754565A Green dendrobium stem compostition and its preparation method |
| 04/05/2006 | CN1754564A Green dendrobium stem pharmaceutical compostition and its preparation method |
| 04/05/2006 | CN1249225C Preparation and application of recombined human betaine homocysteine methyl transferase |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249036C Iron chelators and use thereof |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1249018C Triaryl methane compounds for sickle cell disease |
| 04/05/2006 | CN1248686C Application of 5-amino-levulinic acid in swine growth promoters |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022710 A1 adenosine receptor antagonists |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022699 Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 04/04/2006 | US7022695 Thioether-substituted benzamides as inhibitors of Factor Xa |
| 04/04/2006 | US7022689 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022672 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 04/04/2006 | US7022521 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 04/04/2006 | CA2188507C Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 04/04/2006 | CA1341503C Molecular cloning and expression of human il-3 |
| 03/30/2006 | WO2006034451A2 Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| 03/30/2006 | WO2006033287A1 PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND GLUTATHIONE |
| 03/30/2006 | WO2006032510A1 Extracts from roots and/or shoots of asparagus officinalis l., their preparation and their use |
| 03/30/2006 | WO2006032342A2 Carbonyl compound-containing drug and the use thereof |
| 03/30/2006 | WO2005060940A3 Method for the production of a solid, orally applicable pharmaceutical composition |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069097 N-[3-(trifluoromethyl)phenyl]-4-{2-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-b]pyridazin-3-yl}pyrimidin-2-amine; enzyme inhibitors; inhibition/antagonism of protein kinases, glycogen synthase kinase-3-beta; central nervous system disorders; Alzheimer's disease; bipolar disorder; stroke; anticarcinogenic |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069062 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060068027 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 03/30/2006 | CA2581657A1 Thrombopoietin receptor agonists |
| 03/30/2006 | CA2581172A1 Carbonyl compound-containing drug and the use thereof |
| 03/30/2006 | CA2578735A1 Extracts from roots and/or shoots of asparagus officinalis l., their preparation and their use |
| 03/29/2006 | EP1640016A1 Extracts from roots and/or shoots of Asparagus Officinalis L., their preparation and their use |
| 03/29/2006 | EP1640003A2 Compositions comprising a Cyclooxygenase-2 Inhibitor and a Leukotriene B4 receptor antagonist |
| 03/29/2006 | EP1638596A2 Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases |
| 03/29/2006 | EP1638540A2 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 03/29/2006 | EP1379253B1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/29/2006 | EP1289552B1 Methods for treating hemostatic disorders by soluble p-selectin |
| 03/29/2006 | EP1218024B1 Aspartame derivatives for decreasing blood viscosity |
| 03/29/2006 | EP1124567B1 Buffered compositions for dialysis |
| 03/29/2006 | EP1077715B1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0946715B1 Use of a modified protein c |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | CN1753885A Optically active dihydropyridine derivative |
| 03/29/2006 | CN1753882A Ethynyl derivatives serving as factor XA inhibitors |
| 03/29/2006 | CN1751716A Traditional Chinese medicine for tonifying-blood, prepn. method and quality control method therefor |
| 03/29/2006 | CN1751710A Novel administration route of injection-free type used in summer, prepn. process and indication thereof |
| 03/29/2006 | CN1751707A Soft capsule contg. clinopodium polycephalum and preparing method thereof |
| 03/29/2006 | CN1751692A Medicine Rb2 used for thrombolysis, anti reperfusion injury, improving microcirculation and repairing injured tissue and its prepn. method |
| 03/29/2006 | CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247257C Stable erythropoietin of recombined human red blood cell |
| 03/29/2006 | CN1247256C Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect |
| 03/29/2006 | CN1247244C A series of Chinese traditional medicine for treating blood disease |
| 03/29/2006 | CN1247231C Health care medicine for enriching blood in puerperium and its preparation and uses |
| 03/29/2006 | CN1247214C Hard capsule agent for treating gynaopathy and its preparing method |
| 03/28/2006 | US7019123 Human bikunin |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018630 administering subtilisins obtained from grampositive bacterial residues that vitamin k2 has been removed using chitosan |
| 03/28/2006 | US7018395 to destroy or impair target cells expressing a vascular endothelial growth factor (VEGF) receptor by administering a liposome system of conjugated antibodies, conjugated photosensitizer and another liposome conjugate and using light of an intensity such that nontarget cells are not destroyed |
| 03/28/2006 | CA2415750C Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006001954A3 Methods for promoting the formation of platelets and for treating blood and bone marrow disorders |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063714 Liquid, aqueous, pharmaceutical compositions of factor VII polypeptides |
| 03/23/2006 | US20060063244 Comprises ribonuclease barnase marker gene; libraries; drug resistance |
| 03/23/2006 | US20060062785 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia |
| 03/23/2006 | DE102004045796A1 Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung Medicines containing carbonyl compounds and their use |
| 03/23/2006 | DE102004037805B3 Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen Heat treatment process for fibrinogen pharmaceutical preparations |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/22/2006 | EP1637162A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637148A1 Novel therapeutic use of polypodium extracts |
| 03/22/2006 | EP1636365A1 Cholesterol biosynthesis pathway modulators and uses thereof |
| 03/22/2006 | EP1636226A1 AZAINDOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/22/2006 | EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/22/2006 | EP1636192A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 03/22/2006 | EP1635861A1 Compositions comprising factor viii and factor ixa for treating haemophilia |
| 03/22/2006 | EP1635857A1 TREATMENT OF HAEMORRHAGIC SHOCK USING COMPLEMENT 5a RECEPTOR INHIBITORS |